Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-25 @ 2:43 AM
NCT ID:
NCT05816733
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years
* Patients with persistent or long-term persistent atrial fibrillation who need isolated surgical Cox-Maze IV procedure
* Patients who need cardiac surgery combined with Cox-Maze IV procedure
* Patients who have the ability and willingness to abide by all the subsequent reviews and requirements
* Sign the informed consent
Exclusion Criteria:
* Dapagliflozin allergy
* Hyperthyroidism
* Patients with acute myocardial infarction, cerebral apoplexy, and other vascular diseases during the past 6 months
* Patients who received heart surgery within the last 3 months
* eGFR\<45ml/min
* History of oral SGLT2i
* Estimated survival period \< 12 months
* Pregnant and lactating women
* Left atrial diameter \> 65 mm
* Refusing to sign the informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05816733
Study Brief:
Protocol Section:
NCT05816733